Literature DB >> 20132949

Risk factor analysis for postoperative acute respiratory distress syndrome and early mortality after pneumonectomy: the predictive value of preoperative lung perfusion distribution.

Joon Bum Kim1, Sei Won Lee, Seung-Il Park, Yong Hee Kim, Dong Kwan Kim.   

Abstract

OBJECTIVES: This study aims to establish the preoperative risk factors in the development of acute respiratory distress syndrome (ARDS) and early mortality after pneumonectomy for lung cancer and to examine the influence of reduced pulmonary perfusion on outcomes.
METHODS: Between 1994 and 2009, of 425 patients who underwent simple pneumonectomy for primary lung cancer, 164 who were preoperatively evaluated with lung perfusion scanning formed the population of this study.
RESULTS: Of 30 (18.3%) patients who had major pulmonary complications, 17 (10.4%) progressed to ARDS, 15 of whom subsequently died. On multivariable logistic regression analyses, lower predicted postoperative forced expiratory volume in 1 second (ppo-FEV(1); relative risk of 0.93 [P = .020] for ARDS and 0.94 [P = .027] for mortality) and greater perfusion fraction of resected lung (relative risk of 1.10 [P = .003] for ARDS and 1.09 [P = .002] for mortality) were found to be independent factors associated with ARDS and early mortality. With a cut-off value of 35% for perfusion fraction of resected lung, patients with a perfusion fraction of greater than 35% had a greater incidence of ARDS (17.3% vs 3.3%, P = .005) and early mortality (19.8% vs 6.0%, P = .010) than those with a perfusion fraction of 35% or less.
CONCLUSIONS: Patients with a low ppo-FEV(1), a high perfusion fraction of resected lung, or both had a higher incidence of ARDS and early mortality after pneumonectomy. Therefore, although the ppo-FEV(1) appears to be within an acceptable limit for pneumonectomy, much attention should be given to patients with a high perfusion fraction of resected lung. 2010 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20132949     DOI: 10.1016/j.jtcvs.2009.11.021

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

Review 1.  The utility of clinical predictors of acute lung injury: towards prevention and earlier recognition.

Authors:  Joseph E Levitt; Michael A Matthay
Journal:  Expert Rev Respir Med       Date:  2010-12       Impact factor: 3.772

2.  Predictors of post-pneumonectomy respiratory failure and ARDS: usefulness of normalized pulmonary artery diameter.

Authors:  Marine Peretti; Remi Hervochon; Mauro Loi; Kim Blanc; Nicolas Roche; Marco Alifano
Journal:  Intensive Care Med       Date:  2018-05-11       Impact factor: 17.440

3.  Preoperative pulmonary vascular morphology and its relationship to postpneumonectomy hemodynamics.

Authors:  Farbod N Rahaghi; Daniel Lazea; Saba Dihya; Raúl San José Estépar; Raphael Bueno; David Sugarbaker; Gyorgy Frendl; George R Washko
Journal:  Acad Radiol       Date:  2014-06       Impact factor: 3.173

4.  Early identification of patients at risk for acute respiratory distress syndrome among severe pneumonia: a retrospective cohort study.

Authors:  Jian Luo; He Yu; Yue-Hong Hu; Dan Liu; Yi-Wei Wang; Mao-Yun Wang; Bin-Miao Liang; Zong-An Liang
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

5.  High-frequency power of heart rate variability can predict the outcome of thoracic surgical patients with acute respiratory distress syndrome on admission to the intensive care unit: a prospective, single-centric, case-controlled study.

Authors:  I-Chen Chen; Chew-Teng Kor; Ching-Hsiung Lin; Jane Kuo; Jang-Zern Tsai; Wen-Je Ko; Cheng-Deng Kuo
Journal:  BMC Anesthesiol       Date:  2018-04-02       Impact factor: 2.217

6.  Normalized Pulmonary Artery Diameter Predicts Occurrence of Postpneumonectomy Respiratory Failure, ARDS, and Mortality.

Authors:  Elisa Daffrè; Mathilde Prieto; Haihua Huang; Aurélie Janet-Vendroux; Kim Blanc; Yen-Lan N'Guyen; Ludovic Fournel; Marco Alifano
Journal:  Cancers (Basel)       Date:  2020-06-10       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.